Partners, LP MFN, a 10% owner of $RXO, bought 532,276 shares of the company on 02-12-2026 for an estimated $6,387,312. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 1.9%. Following this trade, they now own 28,109,942 shares of this class of $RXO stock.
$RXO Insider Trading Activity
$RXO insiders have traded $RXO stock on the open market 7 times in the past 6 months. Of those trades, 6 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $RXO stock by insiders over the last 6 months:
- PARTNERS, LP MFN purchased 532,276 shares for an estimated $6,387,312
- JASON S. KERR (Chief Accounting Officer) sold 33,343 shares for an estimated $385,778
- THOMAS A SZLOSEK purchased 20,308 shares for an estimated $251,209
- ANDREW M. WILKERSON (Chief Executive Officer) has made 2 purchases buying 11,625 shares for an estimated $149,422 and 0 sales.
- ADRIAN KINGSHOTT purchased 9,350 shares for an estimated $100,512
- TROY A. COOPER purchased 8,317 shares for an estimated $88,243
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RXO Hedge Fund Activity
We have seen 115 institutional investors add shares of $RXO stock to their portfolio, and 172 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,302,185 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $35,407,605
- FINEPOINT CAPITAL LP added 2,121,950 shares (+29.2%) to their portfolio in Q4 2025, for an estimated $26,821,448
- ORBIS ALLAN GRAY LTD added 2,104,597 shares (+6.5%) to their portfolio in Q4 2025, for an estimated $26,602,106
- FRANKLIN RESOURCES INC removed 1,841,150 shares (-79.1%) from their portfolio in Q4 2025, for an estimated $23,272,136
- LOOMIS SAYLES & CO L P removed 1,307,867 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $20,114,994
- NORGES BANK removed 1,078,164 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $13,627,992
- RIVULET CAPITAL, LLC removed 995,750 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $15,314,635
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RXO Revenue
$RXO had revenues of $1.5B in Q4 2025. This is a decrease of -11.88% from the same period in the prior year.
You can track RXO financials on Quiver Quantitative's RXO stock page.
$RXO Analyst Ratings
Wall Street analysts have issued reports on $RXO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 01/15/2026
- Morgan Stanley issued a "Overweight" rating on 11/11/2025
- Barclays issued a "Overweight" rating on 11/07/2025
- Susquehanna issued a "Negative" rating on 11/07/2025
To track analyst ratings and price targets for $RXO, check out Quiver Quantitative's $RXO forecast page.
$RXO Price Targets
Multiple analysts have issued price targets for $RXO recently. We have seen 10 analysts offer price targets for $RXO in the last 6 months, with a median target of $15.5.
Here are some recent targets:
- Lucas Servera from Truist Securities set a target price of $20.0 on 02/09/2026
- Ariel Rosa from Citigroup set a target price of $18.0 on 02/09/2026
- Jason Seidl from TD Cowen set a target price of $14.0 on 01/09/2026
- Bascome Majors from Susquehanna set a target price of $11.0 on 01/08/2026
- J. Bruce Chan from Stifel set a target price of $16.0 on 12/16/2025
- Ravi Shanker from Morgan Stanley set a target price of $19.0 on 11/11/2025
- Brandon Oglenski from Barclays set a target price of $15.0 on 11/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
